Miriam McDonald struggled to get care for postpartum depression at Kaiser Permanente, an experience that would eventually lead to significant policy changes by the health care provider. The lack of guidance for insurance coverage of zuranolone may restrict its accessibility.
Zuranolone represents a novel approach it targets hormone function to relieve symptoms, instead of the brain's serotonin system, as typical antidepressants do. Lawyers, advocates, and regulators are watching closely to see how insurance companies will shape policies for zuranolone.
[
Collection
]
[
|
...
]